Author Archives: Marta Figueiredo PhD

#AANAM – Duodopa/Duopa Eases Advanced Parkinson’s Over Long Term

Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Long-term treatment with Duodopa (levodopa-carbidopa intestinal gel) safely and effectively lessens motor and non-motor symptoms and improves quality of life…

Study: Schizophrenia Increases Risk of Late-life Parkinson’s

People with schizophrenia spectrum disorder have an increased risk of developing Parkinson’s disease later in life, according to both regional and nationwide data from Finland. This higher risk may be associated with medication-induced changes in the brain’s dopamine system — also affected in Parkinson’s patients — or disease-associated mechanisms, and…

Xadago Shows Potential in Small Study to Ease Urinary Problems

Xadago (safinamide) — approved as an add-on therapy to ease “off periods” that can accompany levodopa — may also help with urinary symptoms in people with Parkinson’s disease, a small study reports. These early findings support previous studies showing that Xadago may be addressing Parkinson’s non-motor symptoms. Larger studies are needed…

More Reliable Alpha-synuclein Test Speeds Diagnosis

Researchers have developed a faster method of measuring the rate at which alpha-synuclein protein forms toxic clumps that reliably distinguishes people with Parkinson’s disease from those without the condition. The findings support the use of this test — which cuts by more than half the time required to obtain…

Your Parkinson’s Community

Woman laying down illustration

Visit the Parkinson’s News Today forums to connect with others in the Parkinson’s community.

View Forums